To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Platelet-rich plasma improves pain + quality of life in knee osteoarthritis at 6 months

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
February 2016

Platelet-rich plasma improves pain + quality of life in knee osteoarthritis at 6 months

Vol: 5| Issue: 2| Number:35| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Does intra articular platelet rich plasma injection improve function, pain and quality of life in patients with osteoarthritis of the knee? A randomized clinical trial

Orthop Rev (Pavia). 2014 Sep 18;6(3):5405

Contributing Authors:
SM Rayegani SA Raeissadat MS Taheri M Babaee MH Bahrami D Eliaspour E Ghorbani

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

65 patients with knee osteoarthritis were randomized to receive intraarticular platelet-rich plasma (PRP) injections with exercise or exercise alone. The purpose of this randomized controlled trial was to determine the effect of PRP injections on pain, function, stiffness, and quality of life 6 months after treatment. The results displayed significantly greater improvements in WOMAC total and pain...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue